caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1639105620

Zhiqiang ZhangMD

NephrologyDublin, GAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Zhiqiang Zhang's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 63 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SOLSTAS LAB PARTNERS GROUP LLC4211,718
FAIRVIEW PARK, LIMITED PARTNERSHIP3392,070
YOUNG, CHARLES1731,019
James Darling
Diagnostic Radiology · Cartersville, GA
152627
Donald Nelson
Internal Medicine · Dublin, GA
113720
DVA RENAL HEALTHCARE INC701,239
Paul Mathieu
Hospitalist · Macon, GA
59414
Andre Lewis
Internal Medicine · Dublin, GA
59419
Nicola Revills
Internal Medicine · Dublin, GA
58476
John Shivdat
Emergency Medicine · Perry, GA
58238
George Harrison
Family Practice · Cochran, GA
52550
Charles Brown
Diagnostic Radiology · Savannah, GA
4799
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,333
Unique beneficiaries
—
Total services
3,256
Distinct HCPCS
10
Medicare payment
$334K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 303 Nephrology providers in GA — top quintile (cohort median 1,455).
PRESCRIBING · PART D · 2024
Total Rx claims
6,035
Beneficiaries
—
Total drug cost
$260K
Distinct drugs
70
Brand share
17.6%
Top prescribed drugs
Nifedipine707 claims
Calcitriol639 claims
Bumetanide411 claims
Losartan Potassium305 claims
Doxazosin Mesylate241 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
81.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$134
Payment records
12
By payment type
Education$69
Food and Beverage$65